2. Gene
  3. C2 - complement C2 Gene

C2 - complement C2 Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Macaca fascicularis

基因 ID: 102137096 | 基因类型: protein coding

关于 C2

C2 基因产物(2)

mRNA Protein Name
XM_005553451.3 XP_005553508.1 complement C2 isoform X1
XM_015449603.2 XP_015305089.1 complement C2 isoform X2
蛋白主名 其他名称

complement C2

重组 C2 蛋白

目录号 产品名 蛋白编号 纯度
HY-P700697 C2/Complement C2 Protein, Cynomolgus (HEK293, His) A0A2K5U0I4/XP_005553508.1 (A21-L752) ≥95%

相关产品

Approval
生物活性分子 (3)
目录号 产品名 作用方式
纯度 是否罕见病
HY-14544 Quetiapine 99.88% 是
HY-B0031 Quetiapine hemifumarate 99.94% 是
HY-B1915 Micronomicin Inhibitor 95.16% 否
抗体抑制剂 (1)
目录号 产品名 作用方式
纯度 是否罕见病
HY-P99050 Sutimlimab Inhibitor 98.81% 否
Clinical Phase
生物活性分子 (2)
目录号 产品名 作用方式
纯度 Phase
HY-N0379 D-Mannose ≥98.0% Phase 4
HY-113697 Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD 99.77% Phase 1
抗体抑制剂 (3)
目录号 产品名 作用方式
纯度 Phase
HY-P990091 Riliprubart Inhibitor 99.90% Phase 3
HY-P99163 Tilavonemab Inhibitor 96.22% Phase 2
HY-P990025 Empasiprubart 97.93% Phase 2
Pre-clinical Phase
生物活性分子 (716)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-N0155 Nobiletin 99.52% 否
HY-113071A Mevalonic acid lithium salt 99.80% 否
HY-40171 NH2-C2-NH-Boc 99.97% 否
HY-W021401 Amino-PEG3-C2-Azido 99.67% 否
HY-N0376 Liquiritin 99.68% 否
HY-140213 Azido-PEG2-C2-amine 99.85% 否
HY-130109 N3-PEG4-C2-NHS ester 98.94% 否
HY-117974 Durlobactam sodium Inhibitor 99.38% 否
HY-101180 C2 Ceramide 99.85% 否
HY-42776 NH2-PEG3-C2-NH-Boc 99.34% 否
HY-W008474 Boc-NH-PEG2-C2-NH2 99.01% 否
HY-122502 Pyrazofurin Inhibitor ≥98.0% 否
HY-128834 N3-PEG4-C2-NH2 ≥98.0% 否
HY-100594 EUK-134 Inhibitor 98.08% 否
HY-126528 N3-PEG3-C2-NHS ester 99.94% 否
HY-130653 Azido-PEG4-C2-acid ≥98.0% 否
HY-150795 SY-LB-35 ≥98.0% 否
HY-126526 N3-PEG2-C2-NHS ester ≥98.0% 否
HY-W015088 Amino-PEG3-C2-Amine 99.32% 否
HY-W015913S Sodium 2-oxopropanoate-13C3 Inhibitor 99.7% 否
HY-137320 diABZI-C2-NH2 Agonist 96.09% 否
HY-130485 Bromo-PEG2-C2-azide 98.10% 否
HY-140452 Azido-PEG2-C2-acid ≥97.0% 否
HY-42149 NH2-PEG2-C2-Boc ≥98.0% 否
HY-N0602 Ginsenoside Rg2 Inhibitor 98.11% 否
HY-135804 NH2-PEG3-C2-Boc ≥97.0% 否
HY-112821 IBS008738 Activator 98.22% 否
HY-130549 Acid-PEG3-C2-Boc ≥97.0% 否
HY-W092043 TLR4-IN-C34-C2-COOH Inhibitor ≥97.0% 否
HY-107452 SLF-amido-C2-COOH 99.82% 否
HY-125843 Pomalidomide-PEG1-C2-N3 99.91% 否
HY-W022240 NH2-PEG5-C2-NH-Boc ≥95.0% 否
HY-W011235 Norfluoxetine hydrochloride Inhibitor 99.58% 否
HY-147007 β-catenin-IN-3 Inhibitor 98.03% 否
HY-150644 S07-2010 Inhibitor 99.79% 否
HY-156406 PITCOIN4 Inhibitor 99.97% 否
HY-42151 Mal-amido-PEG2-C2-acid 99.58% 否
HY-140009 Azido-PEG1-C2-acid ≥98.0% 否
HY-D0187S L-Glutathione reduced-13C2,15N Inhibitor ≥99.0% 否
HY-126502 Mal-C2-NHS ester 99.30% 否
HY-130436 Acid-C2-PEG4-C2-NHS ester ≥98.0% 否
HY-W017970 Boc-C2-NH2 99.63% 否
HY-124569 NAB-14 Antagonist 98.26% 否
HY-126520 N3-C2-NHS ester ≥98.0% 否
HY-140480 Acid-PEG2-C2-Boc ≥98.0% 否
HY-112820 Chlorantraniliprole Activator 98.06% 否
HY-141364 Bromo-PEG1-C2-Boc 98.58% 否
HY-148896 (S,R,S)-AHPC-C2-PEG3-BCN ≥98.0% 否
HY-163084 HJ445A Inhibitor 98.31% 否
HY-W040165 Amino-PEG3-C2-acid 99.94% 否
HY-101159 Mal-amido-PEG8-C2-acid 99.04% 否
HY-108307 Micronomicin sulfate Inhibitor ≥98.0% 否
HY-112452 SU11652 99.06% 否
HY-128846A Pomalidomide-C2-NH2 hydrochloride 99.46% 否
HY-148346A STING agonist-20-Ala-amide-PEG2-C2-NH2 TFA Agonist 98.20% 否
HY-22335 Amino-PEG4-C2-amine ≥98.0% 否
HY-W040168 Amino-PEG2-C2-acid ≥98.0% 否
HY-119678 Fortunellin Activator 96.51% 否
HY-124648 SMN-C2 98.85% 否
HY-130315 Br-PEG4-C2-Boc ≥98.0% 否
HY-130483 Br-PEG3-C2-Boc ≥97.0% 否
HY-140127 Azide-C2-SS-C2-biotin 98.79% 否
HY-147025 (S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine 99.06% 否
HY-B0351S2 Taurine-13C2,15N Inducer 98.60% 否
HY-W021448S1 Glycocyamine-15N,13C2 ≥97.0% 否
HY-129703B Thalidomide-PEG2-C2-NH2 hydrochloride Inducer 99.89% 否
HY-112599B Pomalidomide-PEG4-C2-NH2 hydrochloride 97.01% 否
HY-112706 PF-06747711 Antagonist 99.86% 否
HY-131880 Thalidomide-O-C2-acid Inducer 95.04% 否
HY-137531 Pomalidomide-PEG1-C2-COOH 99.76% 否
HY-N0322S5 Cholesterol-13C2 Agonist 99.76% 否
HY-N0543S Allantoin-13C2,15N4 99.90% 否
HY-N1517 Ganoderic acid C2 99.30% 否
HY-W010098S1 Terephthalic acid-13C2 98.58% 否
HY-W580022 Pomalidomide-5'-PEG8-C2-COOH 98.21% 否
HY-128716A Pomalidomide-PEG3-C2-NH2 TFA 99.0% 否
HY-130683 Lenalidomide-propargyl-C2-NH2 hydrochloride 98.04% 否
HY-128832 Nutlin-C1-amido-PEG4-C2-N3 99.19% 否
HY-115384 Amino-PEG5-C2-acid ≥97.0% 否
HY-135868 Mito-apocynin (C2) Inhibitor 98.38% 否
HY-139848 WS-898 Inhibitor 98.14% 否
HY-140543 N-DBCO-N-bis(PEG2-C2-acid) 96.65% 否
HY-141386 Bromoacetamido-PEG2-C2-NHS ester ≥95.0% 否
HY-B0228S10 (R)-3-Hydroxybutanoic acid-13C2 sodium ≥98.0% 否
HY-N7627 Regaloside C ≥99.0% 否
HY-P5881 PKCα (C2-4) inhibitor peptide Inhibitor 99.81% 否
HY-W039168 Bromo-PEG3-C2-acid ≥97.0% 否
HY-Y0262S1 Oxalic acid-13C2 99.45% 否
HY-Y0966S6 Glycine-13C2,15N ≥99.0% 否
HY-N0091S3 Hypoxanthine-13C2,15N ≥91.0% 否
HY-13836 ELQ-300 Inhibitor ≥98.0% 否
HY-122710A Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride Inducer ≥95.0% 否
HY-136163 (S,R,S)-AHPC-C2-NH2 dihydrochloride 98.63% 否
HY-130108 N3-PEG4-C2-Pfp ester ≥97.0% 否
HY-130414 Mal-amido-PEG4-acid 99.39% 否
HY-133597 4-Chlorocatechol 99.37% 否
HY-134512 Aminooxy-PEG3-C2-thiol ≥95.0% 否
HY-140585 N-DBCO-N-bis(PEG2-C2-NHS ester) ≥96.0% 否
HY-140819 Bromo-PEG1-C2-azide 99.45% 否
HY-141240 Hydroxy-PEG2-C2-methyl ester 98.48% 否
HY-141365 Bromo-PEG2-C2-Boc ≥97.0% 否
HY-23167 Acid-PEG4-C2-Boc / 否
HY-Y0966S3 Glycine-13C2 99.10% 否
HY-129703A Thalidomide-PEG2-C2-NH2 TFA Inducer 99.39% 否
HY-107440A Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride Inducer 98.29% 否
HY-112608 CHMFL-PI3KD-317 Inhibitor 98.04% 否
HY-122694A Thalidomide-O-amido-PEG-C2-NH2 hydrochloride Inducer 98.10% 否
HY-130521 Pomalidomide-amido-PEG3-C2-NH2 99.55% 否
HY-100246 CI-1044 Inhibitor 98.02% 否
HY-115450 ONO-0300302 Antagonist 99.43% 否
HY-126512 Propargyl-C2-NHS ester ≥95.0% 否
HY-126688 Mal-C2-Gly3-EDA-PNU-159682 93.43% 否
HY-126881 Fmoc-PEG2-C2-NHS ester 98.89% 否
HY-130095 NHPI-PEG2-C2-NHS ester 98.23% 否
HY-130101 Ald-Ph-amido-PEG4-C2-NHS ester 98.75% 否
HY-130396 DBCO-PEG4-C2-acid 99.22% 否
HY-130520 Bromoacetamido-PEG4-C2-Boc ≥97.0% 否
HY-130531 NH-bis(C2-PEG2-NH-Boc) ≥98.0% 否
HY-131295 PD0325901-O-C2-dioxolane Inhibitor 98.76% 否
HY-134682 Fmoc-NH-PEG5-C2-NH2 98.06% 否
HY-136162 Thalidomide-4-O-C2-NH2 hydrochloride Inducer 99.37% 否
HY-13966S2 2-Deoxy-D-glucose-13C ≥98.0% 否
HY-141362 Bromo-PEG2-C2-acid ≥97.0% 否
HY-145245 TLR4-IN-C34-C2-amide-C6-OH Inhibitor 99.62% 否
HY-148080 Indole-C2-amide-C2-NH2 99.42% 否
HY-162809 XMU-MP-9 98.16% 否
HY-B0031R Quetiapine hemifumarate (Standard) 99.87% 否
HY-B0351S1 Taurine-13C2 Inducer 99.0% 否
HY-B0389S15 D-Glucose-13C2-4 ≥98.0% 否
HY-N6980 Licorice glycoside C2 99.07% 否
HY-W017387S1 Alpha-ketoisocaproic acid-13C2 sodium 98.1% 否
HY-133358 Cbz-NH-PEG12-C2-acid 95.66% 否
HY-W025074 BML-278 Activator 98.49% 否
HY-W128417S 4-(Dimethylamino)phenacyl bromide-13C2,d6 98.14% 否
HY-107440 Thalidomide-O-amido-PEG3-C2-NH2 Inducer / 否
HY-112600A Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 TFA Inducer 99.28% 否
HY-112617A Thalidomide-O-amido-PEG2-C2-NH2 TFA Inducer 99.72% 否
HY-130682 Lenalidomide-propargyl-C2-amido-Ph-NH2 hydrochloride / 否
HY-130853 Thalidomide-NH-PEG2-C2-NH-Boc Inducer 98.37% 否
HY-112599 Pomalidomide-PEG4-C2-NH2 95.11% 否
HY-128591 DIPQUO Activator 98.70% 否
HY-103154 SB228357 Antagonist 99.43% 否
HY-103611 Thalidomide-O-amido-PEG3-C2-NH2 TFA Inducer 99.55% 否
HY-108440 Shz-1 99.88% 否
HY-113071 Mevalonic acid ≥99.0% 否
HY-120773 Fmoc-PEG3-C2-NHS ester ≥95.0% 否
HY-121982 Cyclo(L-Phe-L-Val) Inhibitor 99.88% 否
HY-126381 Boc-N-PEG5-C2-NHS ester 96.91% 否
HY-126507 Mal-amido-PEG1-C2-​NHS ester 99.69% 否
HY-126509 Mal-amido-PEG10-C2-​NHS ester 95.23% 否
HY-128716 Pomalidomide-PEG3-C2-NH2 / 否
HY-128716B Pomalidomide-PEG3-C2-NH2 hydrochloride / 否
HY-128846 Pomalidomide-C2-NH2 / 否
HY-128848 Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH 95.02% 否
HY-130097 Ald-Ph-amido-PEG4-C2-acid 99.09% 否
HY-130104 Ald-Ph-amido-PEG2-C2-NHS ester 98.51% 否
HY-130470 Chloroacetamido-PEG4-C2-Boc / 否
HY-131866 (S,R,S)-CO-C2-acid ≥98.0% 否
HY-133070 Tos-PEG5-C2-Boc / 否
HY-135085 Thiol-C2-PEG2-OH ≥97.0% 否
HY-136395 Cartap Inducer / 否
HY-13677S1 6-Mercaptopurine-13C2,15N ≥96.0% 否
HY-138446 Amino-PEG4-C2-SH hydrochloride ≥95.0% 否
HY-138451 Amino-PEG7-C2-SH hydrochloride ≥98.0% 否
HY-140779 Azido-PEG6-C2-Boc 99.77% 否
HY-141380 Bromoacetamido-PEG2-C2-acid 99.11% 否
HY-141941S Triazole Lactic Acid-13C2, 15N3 / 否
HY-148136 sEH inhibitor-7 Inhibitor 99.71% 否
HY-148346 STING agonist-20-Ala-amide-PEG2-C2-NH2 Agonist / 否
HY-148484 Pomalidomide-5'-PEG5-C2-COOH 98.80% 否
HY-160897 Methoxy-PEG-C3-amide-C2-Mal 99.69% 否
HY-164367 Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT / 否
HY-16973S Fluralaner-13C2,15N,d3 Inhibitor 98.35% 否
HY-17563S2 2'-Deoxyguanosine-13C10 99.8% 否
HY-66005S4 Acetaminophen-13C2,15N / 否
HY-A0132S10 N-Acetyl-D-glucosamine-13C2,15N / 否
HY-B0166S3 L-Ascorbic acid-13C-2 ≥95.0% 否
HY-B0318S Metronidazole-13C2,15N2 99.30% 否
HY-I0960S Uracil-13C2,15N2 ≥97.0% 否
HY-N0229S15 L-Alanine-13C2,15N ≥99.0% 否
HY-N0229S9 L-Alanine-13C2 ≥98.0% 否
HY-N0437S3 Progesterone-13C2 Agonist 99.7% 否
HY-N0455AS5 L-Arginine-1,2-13C2 hydrochloride Activator 98.9% 否
HY-N0666S6 L-Aspartic acid-1,4-13C2 ≥99.0% 否
HY-N0830S10 Palmitic acid-13C2 Activator 99.54% 否
HY-P2741 Maltose phosphorylase / 否
HY-W013636S3 2-Ketoglutaric acid-13C ≥97.0% 否
HY-W040329S1 2'-Deoxyadenosine-13C10 ≥99.0% 否
HY-W040795 N2-Acetylguanine 99.69% 否
HY-W127841 Citric acid-2,4-13C2 98.00% 否
HY-Y0674S Dicyandiamide-13C2,15N2 99.90% 否
HY-Y0966S2 Glycine-2-13C 99.30% 否
HY-103708 Nezukone 98.81% 否
HY-159193S DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C2,15N)HTTPLPVTDT TFA 97.61% 否
HY-47373 Folate-PEG3-C2-acid 97.56% 否
HY-Y0051S 5-Hydroxymethylfurfural-13C6 ≥98.0% 否
HY-112600 Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 Inducer / 否
HY-112617 Thalidomide-O-amido-PEG2-C2-NH2 Inducer / 否
HY-112617B Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride Inducer / 否
HY-122694 Thalidomide-O-amido-PEG-C2-NH2 Inducer / 否
HY-128353 ROR agonist-1 Antagonist / 否
HY-129703 Thalidomide-PEG2-C2-NH2 Inducer / 否
HY-131308 Thalidomide-NH-C2-PEG3-OH Inducer / 否
HY-136160 Thalidomide 4'-oxyacetamide-alkyl-C2-amine hydrochloride Inducer / 否
HY-141662 2',3'-cGAMP-C2-PPA Agonist / 否
HY-122710 Thalidomide-O-amido-PEG4-C2-NH2 / 否
HY-125883 Pomalidomide-amido-C4-amido-PEG2-C2-NH-Boc / 否
HY-100441S1 Treprostinil-13C2,d1 Inhibitor / 否
HY-100582S1 Ribitol-2-13C / 否
HY-101047S1 D-erythro-Sphingosine-13C2,d2 / 否
HY-101108S1 Tazarotenic acid-13C2,d2 / 否
HY-101400S4 Deoxycytidine triphosphate-13C9 dilithium Activator / 否
HY-103155 SB-221284 Antagonist / 否
HY-106950CS1 Fosfructose-2-13C sodium / 否
HY-107698 PMPA (NMDA antagonist) Antagonist / 否
HY-108379 Boc-C2-Urea-bis(Boc)-C4-Urea-4-phenylacetic acid / 否
HY-108826 Iduronate sulfatase / 否
HY-109506S9 DPPC-13C2 / 否
HY-110189S Pregnenolone monosulfate sodium-13C2,d2 / 否
HY-111095S3A D-(-)-Lactic acid-13C-2 sodium / 否
HY-113071C (S)-Mevalonic acid / 否
HY-113251S1 2-Hydroxyestrone-13C6 Inhibitor / 否
HY-113252S1 2-Methoxyestrone-13C6 / 否
HY-113263S1 17α-Hydroxypregnenolone-13C2,d2 / 否
HY-113295S Salicyluric acid-13C2,15N / 否
HY-113365S2 Cholestenone-13C2 / 否
HY-115945 Complex III-IN-1 Inhibitor / 否
HY-116463A (2R,3S)-E1R Agonist 98.84% 否
HY-116877 C2 Ceramide (d14:1/2:0) / 否
HY-117356A MRS2693 ammonium / 否
HY-117792 LY314228 Antagonist / 否
HY-118574 UBP141 Antagonist / 否
HY-12033S1 2-Methoxyestradiol-13C6 / 否
HY-120678 DBCO-PEG4-acid / 否
HY-121507 Hydroxy-PEG2-C2-sulfonic acid / 否
HY-123439 FTY720-C2 / 否
HY-124489S 2-Hydroxyestradiol-13C6 / 否
HY-125172 PolyQ aggregation inhibitor C2-8 / 否
HY-125887 Boc-NH-PEG2-C2-amido-C4-acid / 否
HY-126026 NF-κB-IN-17 Inhibitor / 否
HY-126313 BnOH-NH-bis-(C2-S)-propane-O-isoprene ester / 否
HY-126508 Mal-amido-PEG5-C2-​NHS ester / 否
HY-12650S Mirogabalin-13C2,d1 (Mixture of Diastereomers) / 否
HY-126510 MC-PEG2-C2-​NHS ester / 否
HY-126514 Propargyl-O-C1-amido-PEG2-C2-NHS ester / 否
HY-126515 Propargyl-O-C1-amido-PEG4-C2-NHS ester / 否
HY-126527 N3-PEG2-C2-PFP ester / 否
HY-126529 N3-PEG3-C2-PFP ester / 否
HY-126673 Mal-C2-Gly3-EDA / 否
HY-126677 Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA / 否
HY-126949 Aminooxy-PEG3-azide / 否
HY-128741S2 D-Allose-13C-2 / 否
HY-128753S3 D-Lyxose-13C-2 / 否
HY-128793S trans-Stilbene-13C2 / 否
HY-129772 Phthalimide-PEG3-C2-OTs / 否
HY-130090 NHPI-PEG4-C2-Pfp ester / 否
HY-130091 NHPI-PEG4-C2-NHS ester 98.88% 否
HY-130092 NHPI-PEG3-C2-Pfp ester / 否
HY-130093 NHPI-PEG3-C2-NHS ester / 否
HY-130094 NHPI-PEG2-C2-Pfp ester / 否
HY-130096 Ald-Ph-amido-C2-nitrate / 否
HY-130102 Ald-Ph-amido-PEG3-C2-Pfp ester / 否
HY-130103 Ald-Ph-amido-PEG2-C2-Pfp ester / 否
HY-130105 Ald-Ph-amido-PEG1-C2-Pfp ester / 否
HY-130106 Ald-Ph-amido-PEG1-C2-NHS ester / 否
HY-130154 Ald-Ph-amido-PEG2-C2-acid / 否
HY-130164 Bromo-PEG3-C2-phosphonic acid / 否
HY-130174 Ald-Ph-amido-PEG3-C2-NH2 / 否
HY-130192 Cbz-NH-PEG8-C2-acid / 否
HY-130202 Ald-Ph-amido-PEG2-C2-Boc ≥97.0% 否
HY-130443 Cbz-NH-PEG6-C2-acid / 否
HY-130467 DNP-NH-PEG2-C2-acid / 否
HY-130488 Hydroxy-PEG2-C2-PFP ester / 否
HY-130489 Bromo-PEG5-C2-acid / 否
HY-130491 DNP-NH-PEG4-C2-Boc / 否
HY-130599 Hydroxy-PEG2-CH2-Boc / 否
HY-130654 (S,R,S)-AHPC-C2-PEG4-N3 / 否
HY-130667 Ald-Ph-amido-C2-PEG3-azide 98.92% 否
HY-130669 Ald-Ph-amido-C2-PEG3-NH-Boc / 否
HY-130690 Propargyl-PEG1-SS-PEG1-C2-Boc ≥98.0% 否
HY-130712 NH2-C2-amido-C2-Boc / 否
HY-130713 Thalidomide-C2-amido-C2-COOH Inducer / 否
HY-130758 Ald-PEG1-C2-Boc / 否
HY-130931 Propargyl-NH-PEG3-C2-NHS ester / 否
HY-131992 N-Acetylpsychosine / 否
HY-132973 MC-Val-Cit-PAB-NH-C2-NH-Boc ≥95.0% 否
HY-133069 Tos-PEG2-C2-Boc / 否
HY-133071 Tos-PEG6-C2-Boc / 否
HY-133410 Mal-C2-cyclohexylcarboxyl-hydrazide TFA / 否
HY-133410A Mal-C2-cyclohexylcarboxyl-hydrazide hydrochloride 98.23% 否
HY-133509 DBCO-C2-SulfoNHS ester / 否
HY-133546 Ald-Ph-amido-PEG11-C2-NH2 / 否
HY-133583 Propargyl-O-C1-amido-PEG3-C2-NHS ester / 否
HY-133694S 2-Aminoflubendazole-13C6 / 否
HY-13407S Gossypol-13C2 / 否
HY-13417S AICAR-13C2,15N / 否
HY-13458S1 Droxidopa-13C2,15N hydrochloride / 否
HY-135931 m-PEG11-C2-NHS Ester / 否
HY-135959 DBCO-NH-PEG7-C2-NHS ester / 否
HY-136162A Thalidomide-4-O-C2-NH2 Inducer / 否
HY-136163A (S,R,S)-AHPC-C2-NH2 / 否
HY-13623CS (1R,3S,4R)-ent-Entecavir-13C2,15N / 否
HY-13623S1 Entecavir-13C2,15N / 否
HY-136457S 2-NP-AHD-13C3 / 否
HY-136648S5 2'-Deoxyadenosine-5'-triphosphate-13C10 dilithium / 否
HY-138083 Parvodicin C2 Inhibitor / 否
HY-138098 Sartorypyrone B / 否
HY-138316 THP-PEG10-C2-Boc / 否
HY-138349 THP-PEG6-C2-Boc / 否
HY-138358 Azido-PEG23-C2-azide / 否
HY-138362 Br-PEG6-C2-acid / 否
HY-138370 Boc-NH-PEG4-C2-Boc / 否
HY-138375 Mal-PEG5-C2-NH2 hydrochloride / 否
HY-138380 Mal-PEG4-C2-NH2 TFA / 否
HY-138381 Br-PEG6-C2-NHBoc / 否
HY-138384 Br-PEG9-C2-NHBoc / 否
HY-138390 NH2-PEG10-C2-dimethylamino / 否
HY-138397 Boc-NH-PEG15-C2-acid / 否
HY-138399 Boc-NH-PEG22-C2-NH2 / 否
HY-138406 Boc-NH-PEG8-C2-Br / 否
HY-138410 Boc-NH-PEG11-C2-acid / 否
HY-138425 Amino-PEG12-C2-azide / 否
HY-138432 Boc-NH-PEG26-C2-NH2 / 否
HY-138464 Br-Boc-C2-azido / 否
HY-138474 Boc-PEG1-PPG2-C2-azido / 否
HY-138485 Boc-PEG1-PPG2-C2-NH2 / 否
HY-138535 Azide-C2-Azide / 否
HY-138616S3 dGTP-13C10 dilithium / 否
HY-138849 Thalidomide-NH-amido-C2-NH2 Inducer / 否
HY-138849A Thalidomide-NH-amido-C2-NH2 hydrochloride Inducer / 否
HY-138854 Thalidomide-NH-amido-PEG1-C2-NH2 Inducer / 否
HY-138854A Thalidomide-NH-amido-PEG1-C2-NH2 hydrochloride Inducer / 否
HY-138855 Thalidomide-NH-amido-PEG2-C2-NH2 Inducer / 否
HY-138855A Thalidomide-NH-amido-PEG2-C2-NH2 hydrochloride Inducer / 否
HY-138856 Thalidomide-NH-amido-PEG3-C2-NH2 Inducer / 否
HY-138856A Thalidomide-NH-amido-PEG3-C2-NH2 hydrochloride / 否
HY-138857 Thalidomide-NH-amido-PEG4-C2-NH2 / 否
HY-138857A Thalidomide-NH-amido-PEG4-C2-NH2 hydrochloride / 否
HY-138965A Pomalidomide-5-C2-NH2 hydrochloride / 否
HY-139084 XL388-C2-NH2 / 否
HY-139085A XL388-C2-amide-PEG9-NH2 hydrochloride ≥95.0% 否
HY-139085B XL388-C2-amide-PEG9-NH2 TFA 95.97% 否
HY-13966S4 2-Deoxy-D-glucose-13C-1 / 否
HY-140001 Amino-PEG3-C2-sulfonic acid / 否
HY-140011 Acid-C2-PEG3-NHS ester / 否
HY-140067 endo-BCN-PEG2-C2-NHS ester / 否
HY-140085 N-(PEG2-C2-acid)-N-bis(PEG2-propargyl) / 否
HY-140101 Azido-C2-SS-PEG2-C2-acid / 否
HY-140164 Azido-PEG2-C2-sulfonic acid / 否
HY-140221 Azido-PEG1-C2-methylamine / 否
HY-140287 DBCO-C2-PEG4-amine / 否
HY-140294 DBCO-C2-PEG4-NH-Boc / 否
HY-140349 AZD-CO-C2-Ph-amido-Ph-azide / 否
HY-140406 Aminooxy-PEG3-C2-NH-Boc / 否
HY-140487 Cbz-NH-PEG2-C2-acid / 否
HY-140489 Cbz-NH-PEG5-C2-acid / 否
HY-140514 NH-bis(PEG2-C2-acid) / 否
HY-140550 NH-bis(C2-PEG1-azide) / 否
HY-140554 N-Boc-N-bis(C2-PEG1-azide) / 否
HY-140595 m-PEG3-S-PEG1-C2-Boc / 否
HY-140633 Ald-C2-PEG4-azide / 否
HY-140750 Benzyloxy carbonyl-PEG3-C2-Boc / 否
HY-140776 Azido-PEG2-C2-Boc / 否
HY-140834 Boc-N-Amido-PEG2-C2-azide / 否
HY-141116 Boc-N-PEG1-C2-NHS ester / 否
HY-141122 Boc-PEG4-C2-NHS ester / 否
HY-141199 Bromoacetamido-C2-PEG2-NH-Boc / 否
HY-141212 Hydroxy-PEG3-PFP ester / 否
HY-141239 Hydroxy-PEG1-C2-methyl ester / 否
HY-141241 Hydroxy-PEG3-C2-methyl ester / 否
HY-141242 Hydroxy-PEG4-C2-methyl ester / 否
HY-141243 Hydroxy-PEG5-C2-methyl ester 98.97% 否
HY-141245 Hydroxy-PEG4-C2-nitrile / 否
HY-141323 C2-Bis-phosphoramidic acid diethyl ester / 否
HY-141349 S-Acetyl-PEG3-C2-acid / 否
HY-141381 Bromoacetamido-PEG3-C2-acid / 否
HY-141388 Bromoacetamido-PEG3-C2-Boc / 否
HY-141663 2',3'-cGAMP-C2-SH / 否
HY-141798 OICR-9429-N-C2-NH2 / 否
HY-141878 di-Ellipticine-RIBOTAC Modulator / 否
HY-143784S C14 Benzalkonium-1 acid-13C2,d11 chloride / 否
HY-143943S Felodipine 3,5-dimethyl ester-13C2,d6 / 否
HY-144128 hGGPPS-IN-1 / 否
HY-144129 hGGPPS-IN-2 / 否
HY-144130 hGGPPS-IN-3 / 否
HY-144150S Pelubiprofen impurity 2-13C2,d6 / 否
HY-144153S S-(1,2-Dichlorovinyl)glutathione-13C2,15N / 否
HY-144427S Vitamin E-13C2,d6 / 否
HY-145247 Biotin-PEG7-C2-S-Vidarabine Inhibitor / 否
HY-145248 Biotin-PEG7-C2-NH-Vidarabine-S-CH3 Inhibitor / 否
HY-145253 Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH Inhibitor / 否
HY-145255 Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH Inhibitor / 否
HY-14608S10 L-Glutamic acid-13C2 / 否
HY-146194 NHEJ inhibitor-1 Activator / 否
HY-146196 Anticandidal agent-1 Inhibitor / 否
HY-146573 AKR1C3-IN-6 Inhibitor / 否
HY-146966S 2-NP-DNSAH-13C6 / 否
HY-146994S2 L-Idose-13C-2 / 否
HY-146995S1 Glycolaldehyde-2-13C / 否
HY-147716 CDK8-IN-6 Inhibitor / 否
HY-147717 CDK8-IN-7 Inhibitor / 否
HY-147835 Antibacterial agent 109 Inhibitor / 否
HY-148171 L-2'-Fd4C Inhibitor / 否
HY-148472A C2-Amide-C4-NH2 / 否
HY-148662 Pomalidomide-PEG5-C2-NH2 hydrochloride / 否
HY-149255 PTP1B/AKR1B1-IN-2 Inhibitor / 否
HY-150525S Acetyl-1,2 Coenzyme A-13c2 Lithium / 否
HY-150623 SARS-CoV-2 nsp13-IN-2 Inhibitor / 否
HY-150631S Glutathione-glycine-13C2,15N trifluoroacetate / 否
HY-150915S Uracil 4,5-13c2 / 否
HY-150980S 1,2-O-Isopropylidene-β-L-idofuranuronic-6-13C acid γ-lactone / 否
HY-150981S 1,2-O-Isopropylidene-a-D-glucofuranuronic-6-13C acid, γ-lactone / 否
HY-152297 (1S)-1,4-Anhydro-1-C-(2,4-difluorophenyl)-D-ribitol / 否
HY-152305 (1S)-1,4-Anhydro-1-C-(2,4-difluoro-5-methylphenyl)-D-ribitol / 否
HY-152463 4′-C-2-Propen-1-yluridine / 否
HY-153042 Thalidomide-NH-C2-azaspiro[3.5]nonane hydrochloride / 否
HY-153371 50-C2-C9-4tail / 否
HY-153538 AP-C2 Inhibitor / 否
HY-15388S1 Tazarotene-13C2,d2 / 否
HY-155705 BMP agonist 1 / 否
HY-156304 Coumarin-C2-TCO / 否
HY-156305 Coumarin-C2-exo-BCN / 否
HY-156882 Biotin-PEG3-amide-C2-CO-Halofuginone / 否
HY-157386S 8-(o-Fluoro-benzyl)theophylline methylsulfonyl-13C2 / 否
HY-157588 (S)-Thalidomide-Piperazine-CH2-Pyrrolidine-C2-OH Inducer / 否
HY-157749 Thalidomide-piperazine-(S)-CH2-pyrrolidine-C2-O-CH2-COO-C(CH3)3 Inducer / 否
HY-157758 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-CH2-COO-C(CH3)3 Inducer / 否
HY-157759 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-C2-OH Inducer / 否
HY-157760 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-OH Inducer / 否
HY-160449 p53 Activator 10 Activator / 否
HY-160514 LXQ46 Inhibitor / 否
HY-161183 (S)-Thalidomide-O-(1S,3r)-C4H4-N(Me)-Pip-C2-O-C-boc Inducer / 否
HY-161184 Deoxy-thalidomide-piperidine-C-piperazine-C2-OH Inducer / 否
HY-161186 Thalidomide-piperidine-C-azetidine-C2-O-C-boc Inducer / 否
HY-161188 Thalidomide-O-C4H4-N(Me)-piperidine-C2-OH Inducer / 否
HY-161189 Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C-boc Inducer / 否
HY-161190 Thalidomide-piperidine-C-2,6-diazaspiro[3.3]heptane-C2-OH Inducer / 否
HY-161191 Thalidomide-azetidine-piperazine-C2-O-C2-OH Inducer / 否
HY-161197 Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C2-OH Inducer / 否
HY-161199 Thalidomide-azetidine-pyrrolidine-C-piperidine-C2-OH Inducer / 否
HY-161200 Thalidomide-piperazine-C-azetidine-C2-OH Inducer / 否
HY-161202 Thalidomide-piperidine-O-piperidine-C2-OH Inducer / 否
HY-161203 Thalidomide-azetidine-piperazine-C2-O-C-boc Inducer / 否
HY-161250 Pomalidomide-NH-PEG6-amide-C2-CPI-1612 / 否
HY-161393 RB-CO-PEG5-C2-CO-VH032 / 否
HY-161394 SPRT / 否
HY-161767 JWJ-01-306 / 否
HY-161839 AKR1C2/3-IN-1 Inhibitor / 否
HY-161910 SH-E4A-66 Inhibitor / 否
HY-162046 Anticancer agent 178 Inducer / 否
HY-162081 BTK-IN-32 Inhibitor / 否
HY-16271S Kevetrin hydrochloride-13C2,15N3 p53 Activator / 否
HY-163078 C2-Gal-Dox / 否
HY-163224 (S)-PROTAC PTK6 ligand-O-C2-O-piperidine-Boc / 否
HY-163228 PROTAC PTK6 ligand-O-C2-O-piperidine-Boc / 否
HY-163276 OX2R-IN-2 Agonist / 否
HY-163788 C5-CONH-C2-N-CH3 / 否
HY-163903 OH-C2-PEG3-NHCO-C3-COOH / 否
HY-163904 (S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH / 否
HY-163930 (S,R,S)-AHPC-CO-cyclohexane-C2 / 否
HY-163986 Pomalidomide-C2-NHCO-C6 / 否
HY-164210 DBCO-PEG2-C2-acid / 否
HY-164212 DBCO-PEG1-OH / 否
HY-164785 TCO-PEG5-C2-Mal ≥95.0% 否
HY-168016 PROTAC YAP degrader-1 / 否
HY-168019 (R,S,R)-AHPC-PEG2-C2-boc / 否
HY-169082 JQ-1 (carboxylic acid)-NH-C2-NH-COOH / 否
HY-169141 BIIB021-NH-C2-piperidine-CO-Me / 否
HY-169150 JQ-1 carboxylic acid-PEG3-C2-NH2 / 否
HY-169236 COOH-C-PEG2-NHCO-C2-COOH / 否
HY-169237 Pomalidomide-C2-CONH-PEG2-C-COOH / 否
HY-17416AS1 Guanfacine-15N3,13C2 Agonist / 否
HY-17530S Aldicarb sulfone-13C2,d3 / 否
HY-18572S 2,4-D-13C6 Inhibitor / 否
HY-34628S2 Tri-O-acetyl-D-glucal-13C-2 / 否
HY-40171S NH2-C2-NH-Boc-d4 / 否
HY-48394A Bis-S-C2-N(N-Me)-C2-OH dihydrochloride / 否
HY-77956S2 Thyminose-13C-2 / 否
HY-79369S1 Succinic anhydride-13C2 / 否
HY-90009AS Tadalafil-13C2,d3 / 否
HY-A0084S1 Procainamide-13C2 hydrochloride / 否
HY-B0031S2 Quetiapine-d8 fumarate / 否
HY-B0031S3 Quetiapine-d8 hemifumarate / 否
HY-B0031S4 Quetiapine hemifumarate-d8 / 否
HY-B0101S1 Fluconazole-13C2,15N Inhibitor / 否
HY-B0141S5 Estradiol-13C2 Agonist / 否
HY-B0149S3 Tranexamic acid-13C2,15N / 否
HY-B0151S1 Pregnenolone-13C2,d2 / 否
HY-B0216S2 Ethynyl Estradiol-13C2 Agonist / 否
HY-B0220S3 Erythromycin-13C2 Inhibitor / 否
HY-B0228S2 Adenosine-2′-13C / 否
HY-B0234S3 Estrone-13C2 Agonist / 否
HY-B0283S1 Acipimox-13C2,15N2 / 否
HY-B0389S12 D-Glucose-13C-2 / 否
HY-B0389S14 D-Glucose-13C2 / 否
HY-B0389S22 D-Glucose-13C2,d2 / 否
HY-B0400S3 D-Sorbitol-13C-2 / 否
HY-B0495S3 Lamotrigine-13C2,15N / 否
HY-B0495S6 Lamotrigine-13C2,15N2,d3 / 否
HY-B0508S1 Ornidazole-13C2,15N2 Inhibitor / 否
HY-B0523S Anagrelide-13C2,15N,d2 / 否
HY-B0579S3 Cyclosporin A-13C2,d4 Inhibitor / 否
HY-B0712S1 Ceftriaxone-13C2,d3 triethylammonium salt Inhibitor / 否
HY-B0782S1 Acetazolamide-13C2,d3 / 否
HY-B0863S3 Glyphosate-13C2,15N Inducer / 否
HY-B1118S1 Secnidazole-13C2, 15N2 Inhibitor / 否
HY-B1337S5 Choline-13C2 chloride / 否
HY-B1449S3 Uridine-13C-2 / 否
HY-B1640S Ethacrynic acid-13C2,d5 / 否
HY-B1659S4 Glycerol-13C2 / 否
HY-B1842S Fluroxypyr-13C2 / 否
HY-B1912S1 Amidosulfuron-13C2,d6 / 否
HY-D0184S5 2'-Deoxycytidine-13C9 / 否
HY-D1546 Biotin-C2-maleimide / 否
HY-D1551 10-(4-(Bis(2-hydroxyethyl)amino)phenyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide / 否
HY-I0400S2 N-Acetylneuraminic acid-13C-2 / 否
HY-I0626S Cytosine-2,4-13C2-1,3-15N2 / 否
HY-I0736S Isonicotinic acid-d4 / 否
HY-N0059S2 D-arabinose-13C-2 / 否
HY-N0090S Guanosine-1'-13C Monohydrate / 否
HY-N0210S1 D-Galactose-13C-2 / 否
HY-N0379S7 D-Mannose-13C-2 / 否
HY-N0390S10 L-Glutamine-1,2-13C2 / 否
HY-N0394S4 L-Cystine-3,3'-13C2 / 否
HY-N0420S3 Butanedioic acid-13C2 ≥99.0% 否
HY-N0420S4 Succinic acid-13C2 / 否
HY-N0473S6 L-Tyrosine-3,5-13C2 99.43% 否
HY-N0537S3 Xylose-2-13C 99.89% 否
HY-N0538S1 Xylitol-2-13C / 否
HY-N0545S Taurocholic acid-13C2,15N sodium Agonist / 否
HY-N0602R Ginsenoside Rg2 (Standard) Inhibitor / 否
HY-N0666S7 L-Aspartic acid-1,4-13C2,15N / 否
HY-N0733S1 Glucosamine-2-13C hydrochloride / 否
HY-N10579 Chrexanthomycin C Modulator / 否
HY-N10595 Ladanetin-6-O-β-(6′′-O-acetyl)glucoside / 否
HY-N10642 Pedaliin 6''-acetate / 否
HY-N10869 Pseudolaric acid C2-O-β-D-glucoside / 否
HY-N1150S4 Thymidine-13C-2 / 否
HY-N1150S5 Thymidine-2′-13C / 否
HY-N12447 C-2′-Decoumaroylaloeresin G / 否
HY-N1420AS2 Rhamnose-13C-2 monohydrate / 否
HY-N1480S2 (-)-Fucose-13C-2 / 否
HY-N3205 Neochamaejasmin B / 否
HY-N3231 Murraol Inhibitor / 否
HY-N3671 Cycloshizukaol A / 否
HY-N3686S2 D-Arabitol-13C-2 / 否
HY-N3697 Demethoxydeacetoxypseudolaric acid B 99.94% 否
HY-N6625S Chlorothalonil-13C2 Inhibitor / 否
HY-N6910 Pseudolaric Acid C2 99.17% 否
HY-N7092S3 D-Fructose-13C2 ≥98.0% 否
HY-N7398S 2-Pentylfuran-13C2 / 否
HY-P10655 Caloxin 1C2 Inhibitor / 否
HY-R00539 hsa-miR-30c-2-3p mimic / 否
HY-R00539A hsa-miR-30c-2-3p agomir / 否
HY-RI00539 hsa-miR-30c-2-3p inhibitor / 否
HY-RI00539A hsa-miR-30c-2-3p antagomir / 否
HY-RS00535 AKR1C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01199 ATP2C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01227 ATP6V1C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01738 C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01740 C2CD3 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01741 C2CD5 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01742 C2orf69 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS05907 GTF3C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS05968 H3C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS05975 H4C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS09537 NR2C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS09538 NR2C2AP Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS09547 NR3C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS09548 Nr3c2 Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS09549 Nr3c2 Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS09609 NT5C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10511 PIK3C2A Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10512 Pik3c2a Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10513 Pik3c2a Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10514 PIK3C2B Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10515 Pik3c2b Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10516 Pik3c2b Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10517 PIK3C2G Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10518 Pik3c2g Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10519 Pik3c2g Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS14017 SULT1C2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-W005355S9 Sodium 2-oxobutanoate-13C4 / 否
HY-W006057AS Sodium 3-methyl-2-oxobutanoate-13C2,d1 / 否
HY-W006057AS17 Sodium 3-Methyl-2-oxobutanoic acid-13C2 / 否
HY-W006057AS3 Sodium 3-methyl-2-oxobutanoate-13C2,d4 / 否
HY-W007318S 2-Iodoaniline-13C6 / 否
HY-W007928S1 1-O-Acetyl 2,3,5-tri-O-benzoyl-beta-D-ribofuranoside-13C-1 / 否
HY-W008507S (R)-2,3-Dihydroxypropanal-3-13C / 否
HY-W008807S Phosphoenolpyruvic acid potassium-13C2 / 否
HY-W010042S2 L-Glucose-13C-2 / 否
HY-W010452S2 3-Hydroxybutyric acid-13C2 sodium / 否
HY-W011683S1 2'-Deoxyadenosine monohydrate-2′-13C / 否
HY-W012684S Ethane-1,2-diamine dihydrochloride-13C2 / 否
HY-W012864S1 (2S,3R)-2,3,4-Trihydroxybutanal-13C-1 / 否
HY-W012864S2 (2S,3R)-2,3,4-Trihydroxybutanal-13C-2 99.4% 否
HY-W013061S5 Propane-1,2,3-triyl tripalmitate-13C2 / 否
HY-W013495S Porphobilinogen-13C2 / 否
HY-W013636S4 2-Ketoglutaric acid-13C2 Inhibitor / 否
HY-W014223S 2,4-Dihydroxybenzophenone-13C6 / 否
HY-W015410S Disodium succinate-13C2 / 否
HY-W015883AS Fumaric acid2,3-13C2 disodium / 否
HY-W015883S2 Fumaric acid-13C2,d2 / 否
HY-W015913S4 2-Oxopropanoate-13c2 sodium / 否
HY-W016009S3 2'-Deoxyadenosine-5'-monophosphate-13C10 dilithium / 否
HY-W017018S1 L-Ornithine-1,2-13C2 hydrochloride / 否
HY-W017072S 1-Dodecene-1,2-13C2 / 否
HY-W017522S6 Adipic acid-13C2 / 否
HY-W018772S16 D-Ribose-1,2-13C2 / 否
HY-W018772S3 D-Ribose-13C-2 / 否
HY-W019796 Cbz-NH-PEG4-C2-acid / 否
HY-W035903S Ethanolamine-13C2 hydrochloride / 否
HY-W040028 Cartap hydrochloride Inducer / 否
HY-W040240S2 (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-2 / 否
HY-W042357S3 Ac-rC Phosphoramidite-13C2,d1 / 否
HY-W048482S rU Phosphoramidite-13C2,d1 / 否
HY-W096111A Trt-PEG4-C2-acid hydrate / 否
HY-W096132 Dimethylamino-PEG2-C2-NH2 / 否
HY-W099580S Hexadecane-1,2-13C2 / 否
HY-W100312S o-Toluidine-13C6 hydrochloride / 否
HY-W338294S1 2'-Deoxycytidine-13C-2 monohydrate / 否
HY-W584529 VH032-C2-NH-Boc / 否
HY-W584532 VH032-O-C2-NH-Boc / 否
HY-W588192S 1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone-13C2,d4 / 否
HY-W590667 C2 Ceramide-1-phosphate / 否
HY-W590670 C20-Dihydroceramide / 否
HY-W766769 Cyproterone Acetate-13C2,d3 Antagonist / 否
HY-W778203 Glycolic acid-13C2 / 否
HY-W780293 2-Phenylphenol-13C6 / 否
HY-W877850 Mal-C5-N-bis(PEG2-C2-acid) / 否
HY-Y0219S 1,2,4-Triazole-13C2,15N3 / 否
HY-Y0262BS Oxalic Acid-13C2 disodium / 否
HY-Y0338S1 Ethylene glycol-13C2 / 否
HY-Y0383S2 Dimethyl terephthalate-13C2-1 / 否
HY-Y0418S2 Dulcite-13C-2 / 否
HY-Y0677S Carbethoxymethyldiethyl phosphonate-C13 / 否
HY-Y0781S3 Pyruvic acid-13C-2 sodium / 否
HY-Y0966S11 Glycine-13C2,15N,d2 / 否
HY-Y0989S2 Acetophenone-1,2-13C2 / 否
HY-Y1088S Hydrocinnamic acid-2,3-13C2 / 否
HY-Y1206S Chloroacetyl chloride-13C2 / 否
HY-Y1250S5 Fmoc-Gly-OH-13C2 / 否
HY-Y1250S6 Fmoc-Gly-OH-13C2,15N Inhibitor / 否
HY-100043S 2-Ethyl-3,5-dimethylpyrazine-13C2 / 否
HY-114293S Acetyl coenzyme A-13C2 lithium Inhibitor / 否
HY-116700 Hinnuliquinone Inhibitor / 否
HY-118560S Tricyclodecenyl acetate-13C2 / 否
HY-119799 UK-500001 Inhibitor / 否
HY-121656 AKR1C2/3-IN-2 / 否
HY-125026 MyomiRs-IN-1 / 否
HY-125571 A 74704 Inhibitor / 否
HY-126830 Antifolate C2 / 否
HY-129252 Prothracarcin Inhibitor / 否
HY-130155 AMPK activator C2 Activator / 否
HY-132212 LH1307 Inhibitor / 否
HY-132223 LH1306 Inhibitor / 否
HY-132644S1 3-Demethyl Thiocolchicine--13C2,d6 / 否
HY-135928 Biotin-C2-S-S-pyridine / 否
HY-140157 N-Me-N-bis(PEG4-C2-Boc) / 否
HY-14164S1 Zileuton-13C2,15N Inhibitor / 否
HY-144348S N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N / 否
HY-149559 Thalidomide-5-O-C2-NH2 hydrochloride 98.01% 否
HY-150006 Pomalidomide-C2-acid / 否
HY-15121S1 L-Theanine-13C2,15N2 / 否
HY-156326S (3E,5E)-Octadien-2-one-13C2 / 否
HY-156326S1 (3E,5Z)-Octadien-2-one-13C2 / 否
HY-158343 Thalidomide-NH-PEG2-C2-CH2 / 否
HY-160069 Fmoc-Gly-Gly-Gly-NH-PEG4-C2-COOH / 否
HY-160235 Pomalidomide-C2-amide-C5-azide / 否
HY-161773 HL389-NHC2-PEG3-C2NH / 否
HY-164043 (S,R,S)-AHPC(Me)-amido-C2-acid / 否
HY-164391 Pomalidomide-C2-amide-C4-Br / 否
HY-165064 C2 L-Erythro ceramide (d18:1/2:0) / 否
HY-165072 C2 3'-Sulfo galactosylceramide (d18:1/2:0) / 否
HY-166226 C2 Sphingomyelin (d18:1/2:0) / 否
HY-167710 CRCD2 / 否
HY-50719S1 2-Acetyl-1-pyrroline-13C5 / 否
HY-76204S1 Glycine ethyl ester-13C2 hydrochloride / 否
HY-B0031S5 Quetiapine-d4-1 fumarate / 否
HY-B0084S3 Dienogest-13C2,15N Agonist / 否
HY-B0124S1 Zonisamide-13C2,15N / 否
HY-B1290S3 2-Phenylethanol-13C2 Inhibitor / 否
HY-N0091S4 Hypoxanthine-13C2,15N-1 / 否
HY-N12156 Ajugasterone C 2-acetate / 否
HY-N12297 Ciwujianoside C2 / 否
HY-N7125S Cinnamyl acetate-13C2 / 否
HY-N7521 Procyanidin C2 / 否
HY-N9484S Menthofuran-13C2 / 否
HY-W001942S2 DL-2-Methylbutyric acid-13C2 / 否
HY-W010392S1 Ethyl 2-methylbutanoate-13C2 / 否
HY-W010489S1 2-Phenylacetaldehyde-13C2 / 否
HY-W012578S1 2-Isopropyl-3-methoxypyrazine-13C3 / 否
HY-W012932S 2,4-Dimethylthiazole-13C3 / 否
HY-W012980S4 Isovaleric acid-13C2 / 否
HY-W012998S1 2,3-Pentanedione-13C2 / 否
HY-W015307S 4-Ethyloctanoic acid-13C2 / 否
HY-W015604S 2,3-Diethyl-5-methylpyrazine-13C2 / 否
HY-W017049S Trifluoroacetic acid-13C2 sodium / 否
HY-W020678S 2-Methylbutanal-13C2 / 否
HY-W102356S1 Phenethyl acetate-13C2 / 否
HY-W127515S trans-2,cis-6-Nonadienal-13C2 / 否
HY-W343292S 2-Methylbutyl acetate-13C2 / 否
HY-W414466 C20-Dihydrosphingosine / 否
HY-W590664 C2 Dihydroceramide / 否
HY-W654105 C18-Ceramide-13C2,d2 / 否
HY-W654190 Fipronil sulfone-13C2,15N2 / 否
HY-W654241 Isopentenyl pyrophosphate-13C2 / 否
HY-W749251 5-Aminolevulinic acid-13C2,15N hydrochloride / 否
HY-W777583 2-[4-(1-Ethyl-1,4-dimethylpentyl)phenoxy]ethanol-13C6 / 否
HY-W778064 L-threo-Droxidopa-13C2,15N / 否
HY-W778154 O,O-Dimethyl dithiophosphate-13C2 ammonium Inhibitor / 否
HY-W778207 2'-Deoxyadenosine-13C5 monohydrate / 否
HY-W779002 alpha-D-glucose-13C2-1 / 否
HY-W923646 C24:1-Dihydro-ceramide / 否
HY-Y0045S 2-Acetylthiazole-13C2 / 否
HY-111555 AmPEG6C2-Aur0131 Inhibitor / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens C2 NCBI NCBI:717
Canis familiaris C2 NCBI NCBI:474853
Mus musculus C2 NCBI NCBI:12263
Rattus norvegicus C2 NCBI NCBI:24231
Macaca mulatta C2 NCBI NCBI:106997899
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z